BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Northstar Neuroscience, Inc. Announces Chief Financial Officer Transition


12/5/2008 7:01:51 AM

SEATTLE, Dec. 5, 2008 (GLOBE NEWSWIRE) -- Northstar Neuroscience, Inc., (NasdaqGM:NSTR - News), a medical device company developing therapies for the treatment of major depressive disorder, announced today that Raymond N. Calvert has resigned as Chief Financial Officer and Vice President, Finance to pursue other interests, effective December 31, 2008.

``Ray has been a valuable member of our management team,'' said John Bowers, Northstar's President and Chief Executive Officer. ``We appreciate the many contributions he has made in his nearly eight years with Northstar. During his tenure, Ray led several rounds of financing, including our highly successful initial public offering, and filled a key leadership role in our organization as we executed our clinical programs. We wish him the best in his future endeavors.'' Northstar also announced that Brian B. Dow has been named Chief Financial Officer and Vice President of Finance, effective January 1, 2009. Mr. Dow brings over 16 years of financial management and accounting experience and has most recently served as Northstar's Director of Finance, having joined Northstar to help execute the Company's 2006 initial public offering. Prior to joining Northstar, Mr. Dow served in roles of progressively-increasing responsibilities in public and private companies in the life sciences and technology industries and has experience with public and private equity financings, debt financings and mergers and acquisitions. Mr. Bowers commented, ``Brian has been an integral leader in our finance organization over the last three years, and has been instrumental in recent strategic initiatives. He has strong knowledge of our business, systems, and all aspects of our financial management, compliance and corporate governance, and I look forward to his leadership in his new role.''

About Northstar Neuroscience

Northstar Neuroscience is a medical device company focused on developing neuromodulation therapies to treat neurological diseases and disorders. Northstar's proprietary Renova(tm) Cortical Stimulation System is an investigational device that delivers targeted electrical stimulation to the outer surface of the brain -- the cerebral cortex. For more information, visit http://www.northstarneuro.com.

Contact:

Northstar Neuroscience, Inc. Investor Relations 206-902-1997 ir@northstarneuro.com

Westwicke Partners Mark Klausner 443-213-0500 mark.klausner@westwicke.com

Schwartz Communications Media: Helen Shik 781-684-0770 northstar@schwartz-pr.com

Source: Northstar Neuroscience, Inc.


Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->